Rep. Byron Donalds bought Merck & Co. (MRK)
Rep. Byron Donalds (R-FL-19) · $1K–$15K · traded Aug 12, 2022
- Transaction
- Bought
- Amount
- $1K–$15K
- Owner
- Not stated
- Traded
- Aug 12, 2022
- Disclosed
- Nov 8, 2024
- Days to disclose
- 819 (after the 45-day deadline)
- Asset type
- Other
- As filed
- Merck & Co Inc (MRK)
- Industry
- Drug Manufacturers - General · Healthcare
Other trades in this filing
All of Donalds's trades →- Nov 8, 2024$1K–$15K
$1K–$15K · Traded May 9, 2024 · disclosed Nov 8, 2024 · Spouse · filed 183 days later
- Nov 8, 2024$1K–$15K
$1K–$15K · Traded May 9, 2024 · disclosed Nov 8, 2024 · filed 183 days later
- Nov 8, 2024$1K–$15K
$1K–$15K · Traded May 9, 2024 · disclosed Nov 8, 2024 · Spouse · filed 183 days later
- Nov 8, 2024$1K–$15K
$1K–$15K · Traded May 9, 2024 · disclosed Nov 8, 2024 · filed 183 days later
- Nov 8, 2024$1K–$15K
$1K–$15K · Traded Mar 27, 2024 · disclosed Nov 8, 2024 · Spouse · filed 226 days later
- Nov 8, 2024$1K–$15K
$1K–$15K · Traded Mar 27, 2024 · disclosed Nov 8, 2024 · filed 226 days later
- Nov 8, 2024$1K–$15K
$1K–$15K · Traded Mar 27, 2024 · disclosed Nov 8, 2024 · Spouse · filed 226 days later
- Nov 8, 2024$1K–$15K
$1K–$15K · Traded Mar 27, 2024 · disclosed Nov 8, 2024 · filed 226 days later
- Nov 8, 2024$1K–$15K
$1K–$15K · Traded Mar 27, 2024 · disclosed Nov 8, 2024 · Spouse · filed 226 days later
- Nov 8, 2024$1K–$15K
$1K–$15K · Traded Mar 27, 2024 · disclosed Nov 8, 2024 · filed 226 days later
- Nov 8, 2024$1K–$15K
$1K–$15K · Traded Mar 27, 2024 · disclosed Nov 8, 2024 · Spouse · filed 226 days later
- Nov 8, 2024$1K–$15K
$1K–$15K · Traded Mar 27, 2024 · disclosed Nov 8, 2024 · filed 226 days later
- Nov 8, 2024$1K–$15K
$1K–$15K · Traded Mar 27, 2024 · disclosed Nov 8, 2024 · Spouse · filed 226 days later
- Nov 8, 2024$1K–$15K
$1K–$15K · Traded Mar 27, 2024 · disclosed Nov 8, 2024 · filed 226 days later
- Nov 8, 2024$1K–$15K
$1K–$15K · Traded Mar 27, 2024 · disclosed Nov 8, 2024 · Spouse · filed 226 days later
- Nov 8, 2024$1K–$15K
$1K–$15K · Traded Mar 27, 2024 · disclosed Nov 8, 2024 · filed 226 days later
- Nov 8, 2024$1K–$15K
$1K–$15K · Traded Feb 22, 2024 · disclosed Nov 8, 2024 · filed 260 days later
- Nov 8, 2024$1K–$15K
Sold General Motors Company GM
$1K–$15K · Traded Feb 22, 2024 · disclosed Nov 8, 2024 · filed 260 days later
- Nov 8, 2024$1K–$15K
Sold Bristol-Myers Squibb Company BMY
$1K–$15K · Traded Feb 22, 2024 · disclosed Nov 8, 2024 · filed 260 days later
- Nov 8, 2024$1K–$15K
$1K–$15K · Traded Feb 22, 2024 · disclosed Nov 8, 2024 · filed 260 days later
Recent Congress trades in MRK
- Nov 5, 2026$15K–$50K
Rep. Ro Khanna (D-CA-17)
$15K–$50K · Traded Oct 7, 2026 · disclosed Nov 5, 2026 · Spouse
- Nov 5, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Oct 2, 2026 · disclosed Nov 5, 2026 · Dependent
- Oct 7, 2026$1K–$15K
Rep. Maria Elvira Salazar (R-FL-27)
Sold (partial) Merck & Co. MRK
$1K–$15K · Traded Sep 24, 2026 · disclosed Oct 7, 2026
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Sep 9, 2026$15K–$50K
Rep. Maria Elvira Salazar (R-FL-27)
$15K–$50K · Traded Aug 19, 2026 · disclosed Sep 9, 2026
- Sep 9, 2026$15K–$50K
Rep. Maria Elvira Salazar (R-FL-27)
$15K–$50K · Traded Aug 19, 2026 · disclosed Sep 9, 2026
- Jul 21, 2026$15K–$50K
Sen. Alan Armstrong (R-OK)
$15K–$50K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Jun 30, 2026$1K–$15K
Rep. Keith Self (R-TX-3)
$1K–$15K · Traded Jan 10, 2025 · disclosed Jun 30, 2026 · filed 536 days later
Company context for MRK
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
MRK: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.
2 congressional households disclosed purchases in the past 90 days. See the trades
MRK: Financial results
Filed 8-K for an event or period dated 2026-10-29. Financial results.
2 congressional households disclosed purchases in the past 90 days. See the trades
MRK: third_quarter 2026 lobbying report
S. 2076, Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act of 2021 Issues relating to, 340B program integrity; 340B of the Public Health Services Act; Drug pricing and reimbursement issues; Vaccine issues; Pharmaceutical supply channel issues; Drug shortages issues; Inflation Reduction Act (P.L. 117-169), issues relating to drug pricing provisions; FY-2027 Budget and Appropriations Legislation; Budget reconciliation drug pricing provisions; Commerce Justice, Science, and related agencies appropriations legislation for 2026; Interior, Environment, and related agen
Public: Oct 20, 2026, 5:25 PM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.